Vanguard Portfolio Management
COGT icon

Vanguard Portfolio Management’s Cogent Biosciences COGT Stock Holding History

Vanguard Portfolio Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312M Buy
8,072,411
+739,078
+10% +$25.9M 0.01% 959
2026
Q1 		$282M Buy
+7,333,333
New +$271M 0.01% 927

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management's COGT Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Cogent Biosciences (COGT) stake by 10% in Q2 2026, buying an estimated $25.9M and bringing the position to 8,072,411 shares worth $312M. The position accounts for 0.01% of the portfolio, ranked #959.

Vanguard Portfolio Management first reported a position in COGT in Q1 2026 and has held it in 2 quarters since. 290 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Vanguard Portfolio Management held 8,072,411 shares of Cogent Biosciences worth $312M as of Q2 2026.
  • Vanguard Portfolio Management bought 739,078 Cogent Biosciences shares in Q2 2026, an estimated $25.9M.
  • Cogent Biosciences made up 0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #959 holding.
  • Vanguard Portfolio Management first reported a position in Cogent Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 290 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.